Multiple inflammatory and serum amyloid a positive telangiectatic hepatic adenomas with glycogenated nuclei arising in a background of nonalcoholic steatohepatitis

Seminars in Liver Disease

Volumn 28, Issue 4, 2008, Pages 434-440

  Lim, Kiat H ^a   Ward, Stephen C ^b   Roayaie, Sasan ^b   Cohen, Emil ^c   Schwartz, Myron ^b   Fiel, M Isabel ^b   Thung, Swan N ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Hepatic adenoma; Inflammatory adenoma; Nonalcoholic steatohepatitis; Telangiectatic adenoma

Indexed keywords

SERUM AMYLOID A;

ABDOMINAL PAIN; ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER RESECTION; LOBECTOMY; NODULAR HYPERPLASIA; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TELANGIECTASIA; TUMOR BLEEDING;

ADENOMA; COMORBIDITY; FATTY LIVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SERUM AMYLOID A PROTEIN; TELANGIECTASIS;

EID: 56649123255     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0028-1091987     Document Type: Review

References (17)

1. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1986;110:331-335
2. Wanless IR, Albrecht S, Bilbao J, et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 1989;2:456-462
3. Nguyen BN, Flejou J-F, Terris B, et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-1463
4. Bioulac-Sage P, Reboiussou S, Cunha AS, et al. Clinical, morphologic and molecular features defining so-called telangiectatic focal nodular hyperplasia of the liver. Gastroenterology 2005;128:1211-1218
5. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740-748
6. Paradis V, Champault A, Ronot M, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007;46:140-146
7. Zucman-Rossi J, Benhamouche S, Godard C, et al. Differential effects of inactivated Axin 1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene 2007;26:774-780
8. Attal P, Vilgrain V, Brancatelli G, et al. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology 2003;228:465-472
9. Peterfy CG, Rosenthall L. Large telangiectatic focal nodular hyperplasia presenting with normal radionuclide studies: case report. J Nucl Med 1990;31:2037-2039
10. Haber M, Rueben A, Oliveiro P, et al. Multiple focal nodular hyperplasia of the liver associated with hemihyperthrophy and vascular malformations. Gastroenterology 1995;108:1256-1262
11. Guindi M. So called telangiectatic focal nodular hyperplasia: a newly recognized variant of hepatic adenoma. Pathol Case Rev 2007;12:154-159
12. Bioulac-Sage P, Balabaud C, Bedossa P, et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007;46:521-527
13. Kim H-S, Kim YA, Kim CJ, et al. Telangiectatic focal nodular hyperplasia of the liver: a case detected at birth. J Korean Med Sci 2003;18:746-750
14. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: a new classification and relationship with HCC. Hepatology 2006;43:515-524
15. Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996;384:458-460
16. Bacq Y, Jacquemin E, Balabaud C, et al. Familial liver adenomatosis associated with hepatocytes nuclear factor 1alpha inactivation. Gastroenterology 2003;125:1470-1475
17. Reznik Y, Dao T, Coutant R, et al. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY3) families. J Clin Endocrinol Metab 2004;89:1476-1480